322 related articles for article (PubMed ID: 28197390)
1. The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200.
Noman MZ; Janji B; Abdou A; Hasmim M; Terry S; Tan TZ; Mami-Chouaib F; Thiery JP; Chouaib S
Oncoimmunology; 2017; 6(1):e1263412. PubMed ID: 28197390
[TBL] [Abstract][Full Text] [Related]
2. CD47 is a direct target of SNAI1 and ZEB1 and its blockade activates the phagocytosis of breast cancer cells undergoing EMT.
Noman MZ; Van Moer K; Marani V; Gemmill RM; Tranchevent LC; Azuaje F; Muller A; Chouaib S; Thiery JP; Berchem G; Janji B
Oncoimmunology; 2018; 7(4):e1345415. PubMed ID: 29632713
[TBL] [Abstract][Full Text] [Related]
3. Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer.
Messeha SS; Zarmouh NO; Soliman KFA
Nutrients; 2021 May; 13(5):. PubMed ID: 34069461
[TBL] [Abstract][Full Text] [Related]
4. Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer.
Xiao M; Hasmim M; Lequeux A; Moer KV; Tan TZ; Gilles C; Hollier BG; Thiery JP; Berchem G; Janji B; Noman MZ
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33803139
[TBL] [Abstract][Full Text] [Related]
5. (-)-Sativan Inhibits Tumor Development and Regulates miR-200c/PD-L1 in Triple Negative Breast Cancer Cells.
Peng F; Xiong L; Peng C
Front Pharmacol; 2020; 11():251. PubMed ID: 32231566
[TBL] [Abstract][Full Text] [Related]
6. EGFR activation induced Snail-dependent EMT and myc-dependent PD-L1 in human salivary adenoid cystic carcinoma cells.
Wang Y; Hu J; Wang Y; Ye W; Zhang X; Ju H; Xu D; Liu L; Ye D; Zhang L; Zhu D; Deng J; Zhang Z; Liu S
Cell Cycle; 2018; 17(12):1457-1470. PubMed ID: 29954240
[TBL] [Abstract][Full Text] [Related]
7. Association of PD-L1 and ZEB-1 expression patterns with clinicopathological characteristics and prognosis in oral squamous cell carcinoma.
Takamaru N; Fukuda N; Akita K; Kudoh K; Miyamoto Y
Oncol Lett; 2022 Mar; 23(3):75. PubMed ID: 35111244
[TBL] [Abstract][Full Text] [Related]
8. miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint.
Li D; Wang X; Yang M; Kan Q; Duan Z
Exp Cell Res; 2019 Jul; 380(1):20-28. PubMed ID: 30904483
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung.
Kim S; Koh J; Kim MY; Kwon D; Go H; Kim YA; Jeon YK; Chung DH
Hum Pathol; 2016 Dec; 58():7-14. PubMed ID: 27473266
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of PD-L1 expression in breast cancer cells through the formation of 3D multicellular cancer aggregates under different chemical and mechanical conditions.
Azadi S; Aboulkheyr Es H; Razavi Bazaz S; Thiery JP; Asadnia M; Ebrahimi Warkiani M
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118526. PubMed ID: 31398408
[TBL] [Abstract][Full Text] [Related]
12. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
Jiang Y; Zhan H
Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
[TBL] [Abstract][Full Text] [Related]
13. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
14. Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells.
Alsuliman A; Colak D; Al-Harazi O; Fitwi H; Tulbah A; Al-Tweigeri T; Al-Alwan M; Ghebeh H
Mol Cancer; 2015 Aug; 14():149. PubMed ID: 26245467
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-β induced epithelial mesenchymal transition in non-small cell lung cancer.
Funaki S; Shintani Y; Kawamura T; Kanzaki R; Minami M; Okumura M
Oncol Rep; 2017 Oct; 38(4):2277-2284. PubMed ID: 28849209
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of programmed cell death 1 and its ligand and the correlation with epithelial-mesenchymal transition in thymic carcinoma.
Funaki S; Shintani Y; Fukui E; Yamamoto Y; Kanzaki R; Ose N; Kanou T; Minami M; Mori E; Okumura M
Cancer Med; 2019 Jan; 8(1):216-226. PubMed ID: 30600651
[TBL] [Abstract][Full Text] [Related]
17. Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.
Akalay I; Tan TZ; Kumar P; Janji B; Mami-Chouaib F; Charpy C; Vielh P; Larsen AK; Thiery JP; Sabbah M; Chouaib S
Oncogene; 2015 Apr; 34(17):2261-71. PubMed ID: 24931170
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway.
Shen M; Xu Z; Xu W; Jiang K; Zhang F; Ding Q; Xu Z; Chen Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):149. PubMed ID: 30961670
[TBL] [Abstract][Full Text] [Related]
19. TET2 Inhibits
Shen Y; Liu L; Wang M; Xu B; Lyu R; Shi YG; Tan L
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34064441
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-β.
Xu Q; Wang L; Li H; Han Q; Li J; Qu X; Huang S; Zhao RC
Int J Oncol; 2012 Sep; 41(3):959-68. PubMed ID: 22766682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
